<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Food allergy and hypersensitivity in children.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Finnish Medical Society Duodecim. Food allergy and hypersensitivity in children. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley &amp; Sons; 2010 Dec 1&amp;nbsp;[Various]. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Finnish Medical Society Duodecim. Paediatric food hypersensitivity and allergy. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley &amp;amp; Sons; 2008 Apr 10 [Various]. [13 references]&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="ICD9CM: Allergy, unspecified, not elsewhere classified  (995.3); General physical examination  (89.7); Unspecified disorder of skin and subcutaneous tissue  (709.9)"/><FieldValue Value="MSH: Anaphylaxis ; Asthma ; Breast Feeding ; Diaries ; Diet ; Digestive System Diseases ; Epinephrine ; Food Hypersensitivity ; Gastrointestinal Diseases ; Growth ; Histamine Antagonists ; Immunologic Tests ; Infant Formula ; Medical History Taking ; Nutritionists ; Pediatrics ; Physical Examination ; Preventive Health Services ; Probiotics ; Referral and Consultation ; Risk Assessment ; Skin Diseases ; Skin Tests ; Vaccination "/><FieldValue Value="MTH: 0.3 ML Epinephrine 0.5 MG/ML Prefilled Syringe [Epipen] ; 0.3 ML Epinephrine 1 MG/ML Prefilled Syringe [Epipen] ; Allergy, unspecified, NEC in ICD9CM ; anaphylaxis ; Antihistamines ; Asthma ; Breast Feeding ; Dermatologic disorders ; Diet ; Digestive System Disorders ; Epinephrine ; Food Allergy ; Gastrointestinal Diseases ; Growth ; Height / growth measure ; Histamine Antagonists ; Hypersensitivity skin testing ; Immunologic Tests ; Infant formula ; Nutritionist ; Pediatrics ; physical examination ; Risk Assessment ; Skin and subcutaneous tissue disorders ; Skin prick test ; Vaccination "/><FieldValue Value="PDQ: therapeutic epinephrine "/><FieldValue Value="SNOMEDCT_US: Anaphylaxis  (39579001); Antihistamine  (372806008); Antihistamine  (6425004); Asthma  (195967001); Avoidance behavior  (284489004); Breast fed  (169741004); Cutaneous hypersensitivity  (21626009); Cutaneous hypersensitivity  (422290000); Dietary finding  (41829006); Disorder of digestive system  (53619000); Disorder of gastrointestinal tract  (119292006); Disorder of skin  (95320005); Disorder of skin AND/OR subcutaneous tissue  (80659006); Elimination diet  (226194001); Epinephrine  (387362001); Epinephrine  (65502005); Food allergy  (414285001); Gastrointestinal food challenge  (252522004); Height / growth measure  (271603002); Hypersensitivity skin testing  (164838003); Hypersensitivity skin testing  (268377001); Hypersensitivity skin testing  (53309004); Infant formula  (412413001); Medication/vaccine injector  (706160004); Pediatric specialty  (394537008); Physical assessment  (302199004); Physical assessment  (5880005); Physical assessment  (81375008); Prick test  (37968009); Risk assessment  (225338004); Special infant formula  (4550001)"/><FieldValue Value="UMD: Injectors, Hand-Held  (16-594); Injectors, Medication/Vaccine  (12-504)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Food hypersensitivity and allergy&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Diagnosis" /><FieldValue Value="Evaluation" /><FieldValue Value="Management" /><FieldValue Value="Prevention" /><FieldValue Value="Risk Assessment" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Allergy and Immunology" /><FieldValue Value="Family Practice" /><FieldValue Value="Internal Medicine" /><FieldValue Value="Nutrition" /><FieldValue Value="Pediatrics" /><FieldValue Value="Preventive Medicine" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Dietitians" /><FieldValue Value="Health Care Providers" /><FieldValue Value="Physicians" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Evidence-Based Medicine Guidelines collect, summarize, and update the core clinical knowledge essential in general practice. The guidelines also describe the scientific evidence underlying the given recommendations.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Children at risk for and with known food hypersensitivity and allergy&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Prevention&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Identification of risk groups and preventative measures &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Preventative measures that may be beneficial:&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Exclusive breast feeding for at least 4 to 6 months &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Probiotic bacteria (the effects are strain-specific) &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The guideline developers considered but did not recommend maternal dietary antigen avoidance during pregnancy/lactation or the delaying of the introduction of solids beyond 4&amp;ndash;6 months of age to reduce the risk of allergy.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Diagnosis/Evaluation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Evaluation of signs and symptoms of food allergy:&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Cutaneous manifestations (e.g., atopic eczema) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Intestinal symptoms &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Respiratory tract symptoms &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Diagnosis of food allergy:&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Elimination and challenge tests (avoid testing older children unless strong indication) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Allergy history &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Suspicion of previous anaphylactic reaction &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The guideline developers considered but did not recommend diagnosis as a result of positive skin prick tests, the presence of specific IgE antibodies, or a patch/epicutaneous test.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Treatment/Management&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Avoidance of foods that cause symptoms &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Alternative nutrients if elimination of important food groups; dietitian's care is preferred &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Administration of antihistamines for allergic reaction; an adrenaline auto-injector for serious systemic reaction &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Follow-up:&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Elimination of foods of no nutritional significance &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Growth monitoring &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Vaccinations according to normal program &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Encouragement of family to expand and rationalise the diet; use of a symptom diary &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Re-evaluation at 5 years (no elimination diets at school-age except with an established diagnosis) &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Incidence of signs and symptoms of food allergy &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Diagnostic accuracy &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Effects of treatment &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Hand-searches of Published Literature (Primary Sources)" /><FieldValue Value="Hand-searches of Published Literature (Secondary Sources)" /><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The evidence reviewed was collected from the Cochrane Database of Systematic Reviews. In addition, the Cochrane Library and medical journals were searched specifically for original publications.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Comprehensive and systematic searches were conducted for all topics for which the Finnish Medical Society Duodecim produces national guidelines. As most of our evidence summaries are based on systematic reviews (of which Cochrane reviews are the most important), the search dates are available in the original reviews.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Specific Search Strategy&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The evidence reviewed was updated with a current care search date of March 31, 2008, with the last comprehensive search on November 11, 2007.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Classification of the Quality of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;3&quot; cellpadding=&quot;5&quot; summary=&quot;Table: Grading the Quality of Evidence&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Code&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Quality of Evidence&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Definition&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;A&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;High&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Further research is very unlikely to change confidence in the estimate of effect.&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Several high-quality studies with consistent results &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;In special cases: one large, high-quality multi-centre trial &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;B&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Moderate&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Further research is likely to have an important impact on confidence in the estimate of effect and may change the estimate.&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;One high-quality study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Several studies with some limitations &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;C&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Low&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Further research is very likely to have an important impact on confidence in the estimate of effect and is likely to change the estimate.&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;One or more studies with severe limitations &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;D&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Very Low&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Any estimate of effect is very uncertain.&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Expert opinion &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;No direct research evidence &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;One or more studies with very severe limitations &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;GRADE (Grading of Recommendations Assessment, Development and Evaluation) Working Group 2011 (modified by the EBM Guidelines Editorial Team).&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Review of Published Meta-Analyses" /><FieldValue Value="Systematic Review" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Not stated" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The levels of evidence [A-D] supporting the recommendations are defined at the end of the &quot;Major Recommendations&quot; field.&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Prolonged elimination diets should not be started unless clearly indicated. There is little reliable evidence on the benefits of long-term elimination diets, for example, in the treatment of atopic dermatitis (Hoare, Li Wan Po, &amp;amp; Williams, 2000). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;An elimination diet started before school age should either be stopped before the child goes to school or proper grounds must be given for its continuation. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Food hypersensitivity refers to both food allergy and food intolerance (Johansson et al., 2001). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;In food allergy, it is possible to demonstrate an immunological mechanism in addition to the symptoms. This is usually done with a skin prick test or by determining food specific immunoglobulin E (IgE) antibodies in the serum. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Epidemiology&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;As many as half of all parents with children aged less than 1-2 years associate some of their child's symptoms with food; however, the majority of these suspicions disappear with time (Eggesbo et al., 1999; Venter et al., 2006). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;In a survey of school children, 24% reported to have, or to have had at some stage, a food allergy (Csonka et al., 2000). &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Prevention&lt;/span&gt;&lt;/strong&gt; &lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;In order to prevent a disease from developing one should be able to reliably identify the appropriate risk group as well as to have access to effective preventative measures. No measures with a preventative effect are available for food allergy. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Maternal dietary antigen avoidance during pregnancy (Kramer &amp;amp; Kakuma, 2006) [&lt;strong&gt;C&lt;/strong&gt;] or lactation (Kramer &amp;amp; Kakuma, 2006) [&lt;strong&gt;D&lt;/strong&gt;] has no preventative effect (Greer et al., 2008; H&amp;oslash;st et al., 2008). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;There is conflicting evidence as regards the effect of breast feeding on the development of atopic disease and food allergy. Exclusive breast feeding for 4&amp;ndash;6 months may provide some protection against the development of atopic eczema (Greer et al., 2008). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;There is no evidence that delaying the introduction of solids to beyond 4&amp;ndash;6 months of age reduces the risk of allergy (Greer et al., 2008). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Probiotic bacteria have reduced the risk of atopic eczema and IgE-mediated allergic disease, and their use may be beneficial. However, the effects are strain-specific (Lee, Seto, &amp;amp; Bielory, 2008; Kukkonen et al., 2007); the most extensively studied strain is &lt;em&gt;Lactobacillus rhamnosus GG&lt;/em&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Causes of Food Allergy&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;In principle, any food that contains proteins can cause allergy. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;In infants, the most common causative agents are milk, egg and wheat. School-age children with pollen allergy may develop symptoms to fresh fruits and root vegetables via cross reactions. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Cow's Milk, Wheat, Barley and Rye Allergy&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Clinically the most significant allergies (R&amp;auml;s&amp;auml;nen &amp;amp; Yl&amp;ouml;nen, 1992). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Encountered in very young children; rarely after pre-school age &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Symptoms caused by these nutritionally important foods usually appear in infancy a few weeks after the food has been introduced to the child's diet. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The diagnosis should be confirmed with a supervised elimination-challenge test. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;See the Finnish Medical Society Duodecim guideline &quot;Cow's milk allergy.&quot; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Birch Pollen Allergy&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Different plant allergens share a similar structure, and many fresh fruits, vegetables and nuts can cause symptoms in the oral mucosa, such as itching and tingling (known as &quot;oral allergy syndrome&quot;). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Tree nuts (e.g., hazel nuts and walnuts) and almonds are common causes of symptoms. Root vegetables capable of causing symptoms include potato, carrot, celery and parsnip. Other vegetables and fruit often acting as allergens are apple, pear, peach, kiwi fruit, plum, mango, tomato and sweet pepper. Occasionally spices can also cause symptoms, including mustard, caraway, turmeric, ginger and cinnamon. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Preparation of fruit and vegetables (cooking and freezing) removes their allergenicity making it possible for the majority of those allergic to birch pollen to consume them. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;After pre-school age, the avoidance of allergens should be based on symptom emergence. Due to cross-reactions, false-positive results are common in skin prick and specific IgE antibody tests, but they correlate poorly with the symptoms and are therefore not recommended. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Other Allergens Causing Pollen-Food Cross Reactions&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Peanuts, soya, fish, shellfish, banana, avocado &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Food Intolerance&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Enzyme deficiency&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;The most common form is lactase deficiency, which leads to lactose intolerance. The symptoms do not emerge until school age or adulthood. &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Biogenic amines that release histamine&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Strawberry, citrus fruit, chocolate, tomato &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Anaphylactic Reaction&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;In theory, any food can act as the causative agent.&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;In children: milk, wheat and egg &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;In children and adults: nuts, seeds, peanuts, fish, shellfish &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Central Questions&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Signs and symptoms: what were the observed symptoms and when did they start, and have the symptoms recurred? What was the timing of the onset of symptoms in relation to food exposure? &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Current diet; has some food already been eliminated and what are the reasons for the elimination? &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Courses of antibiotics (effect on intestinal symptoms) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Skin care (use of moisturising lotions and topical corticosteroids) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Breast feeding (duration of exclusive breast feeding, total duration of breast feeding, the first contact with infant formulas, introduction of complementary foods, any particular maternal diets) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Family history of allergies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Smoking (includes outside, in the car, at the grandparents' house etc.) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Could the patient have a metabolic disorder, coeliac disease or lactose intolerance? &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Growth chart (height, weight, head circumference) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Infant (&amp;lt;1 year)&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;History&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Do symptoms warrant further investigations or are they part of normal infancy? Infants are individual and their temperaments vary, which is reflected in the child's contentment, happiness, crying and sleep-wake pattern. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;The consideration of confounding factors is particularly important. &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The foods that were introduced most recently may be eliminated as a trial and the child observed for the development of symptoms. If this is beneficial, the eliminated foods are reintroduced one at a time. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;It is particularly important that no new foods are added randomly at the time of diagnostic work up. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Any diet that has no effect on the symptoms must be stopped. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;An Older Child&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Food-induced symptoms are unlikely. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cross reactions in birch pollen allergy: see above &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A rash that heals in the summer is not likely to be caused by food allergy (Hoare, Li Wan Po &amp;amp; Williams, 2000). &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Symptoms of Food Allergy&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Cutaneous Manifestations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Urticaria, redness of the skin (immediate reactions), exacerbation of atopic eczema (delayed reaction) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A food substance is often found to be an exacerbating factor in severe atopic eczema in an infant. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Atopic dermatitis may be exacerbated by many factors, including dry winter air, stress and infections. A relapsing-remitting pattern is common, which is challenging in infancy when many new foods are introduced. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Intestinal Symptoms&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Abdominal pain, vomiting, changes in stool consistency, persistent crying and restlessness are delayed reactions that are very difficult to interpret. The frequency of bowel motions varies greatly between individuals. For example, a normal pattern for an infant may be a bowel movement 10 times a day or once a week (provided that the child is well and developing normally). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Of gastrointestinal symptoms, the most obvious one is contact allergy around the mouth and lips which appears almost immediately after ingestion and is therefore easy to connect with the offending food (tomato, citrus fruit and apple in birch pollen allergy). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;All changes in the diet can cause temporary changes in bowel function, which is a normal phenomenon. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Respiratory Tract Symptoms&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Rhinitis, itchy eyes, sneezing and dyspnoea are rare.&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;They are usually associated with a severe systemic reaction with signs of urticaria and anaphylaxis. &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;IgE-mediated symptoms usually occur within minutes and no later than within 1&amp;ndash;2 hours, whereas hours to days may pass before delayed, cell-mediated symptoms occur. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;It is extremely difficult to associate delayed intestinal reactions and exacerbations of atopic eczema with a particular food. A double-blind food challenge may be of use in the diagnosis. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Other Symptoms&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;There is no evidence supporting an association between food (food hypersensitivity) and migraine, arthritis, cystitis or nephritis. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Diagnosis of Food Allergy&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;As a basic rule, testing of older children for food allergy should be avoided unless there is a strong suspicion (Vandenplas et al., 2007). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Elimination and challenge tests form the basis of diagnosis (see Picture 1 in the original guideline document). See the Finnish Medical Society Duodecim guideline &quot;Cow's milk allergy.&quot; For nutritionally important foods (milk and wheat in young children) a more formal elimination&amp;ndash;challenge test should be carried out, for example as follows:&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;The suspected food(s) is totally eliminated from the diet (for 1&amp;ndash;2 weeks). &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;The development/resolution of symptoms is recorded in a symptom diary. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;An improvement or disappearance of symptoms supports the presence of food allergy, but it is not diagnostic. The food needs to be reintroduced (challenge). &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;A small amount of the food is reintroduced to the diet and as long as the child remains asymptomatic the amount is increased gradually to the normal (age-adjusted) daily amount. See the Finnish Medical Society Duodecim guideline &quot;Cow's milk allergy.&quot; &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Symptoms usually reappear no later than 1&amp;ndash;2 days following the reintroduction of the food (symptom diary), provided that the amounts consumed are adequate. Symptoms that appear after 5 days are not indicative of an allergy. &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Immediate reactions can be diagnosed with the aid of a detailed history. There is no need to test for foods that are nutritionally less important, but they can be eliminated from the diet and reintroduced at a later stage. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Suspicion of anaphylactic reactions caused by food: if there is a clear suspicion of an anaphylactic reaction, the patient must not be asked to retry the suspected food at home; the decision concerning allergen challenge should always be made by a specialist. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Positive skin prick tests or the presence of specific IgE antibodies are not sufficient for a diagnosis. Immunoglobulin A (IgA) and immunoglobulin G (IgG) antibodies can be detected in everyone and are not useful in diagnostics. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Pre-school and older children can typically have positive results to skin prick and blood tests, which are of no clinical significance. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A patch or epicutaneous test is a method used in scientific research with selected patients in specialist settings. According to current knowledge this is not a sufficiently reliable test. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Treatment&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Food allergy is treated by avoiding food that causes symptoms. The extent of avoidance depends on the severity of the symptoms; if the symptoms are mild there is no need to totally eliminate the offending food. Otherwise, an attempt should be made to provide a normal age-appropriate diet. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;If nutritionally important foods (milk, cereals) are to be eliminated, it must be ensured that alternative nutrients are provided, and a dietitian should be involved in the care. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The aim is normal growth and development. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The majority of children with food allergy will experience accidental exposure to the offending food. The parents must be instructed to administer antihistamines as first aid for allergic reactions. If the child has had a serious systemic reaction, he/she must carry an adrenaline auto-injector the use of which has been demonstrated. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Prognosis of Food Allergy&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Early childhood food allergies resolve during the first few years of life. Half of children with cow's milk allergy will tolerate milk at the age of 2 years and 75% at the age of 3 years. Cereal and egg allergies also resolve in the majority of children by the time they reach school age. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Follow-up and Organisation of Care&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Individual foods which are of no nutritional significance can be eliminated in primary care if the causal relationship of food to symptoms is clear. Elimination and reintroduction can be carried out at home whilst keeping a symptom diary. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;No adequate studies are available on how these children should be followed up. Clinical experience therefore dictates the follow up routines. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Indications for a referral to a specialist&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;A small infant with widespread eczema or worsening symptoms &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;A small infant with difficult or perplexing symptoms, and the parents are convinced of food allergy &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;An infant in whom food allergy to an important nutrient is suspected (milk, wheat) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Failure to thrive &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Continual self-imposed limitations to diet &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;In primary care&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;The growth of a child on an elimination diet is monitored with growth charts. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Vaccinations are given according to the normal programme. Allergy to egg does not prevent vaccination unless the child has had an anaphylactic reaction to egg. See the Finnish Medical Society Duodecim guideline &quot;Vaccinations.&quot; &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;The family is encouraged to expand and rationalise the diet towards a normal diet. &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;The child's diet should be re-evaluated at 5 years of age at the latest: is the avoidance of certain foods based on an elimination&amp;ndash;challenge test? Should a specialist re-evaluate the situation? &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Target: all elimination diets at school-age should be based on an established diagnosis. &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Related Resources&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Refer to the original guideline document for related evidence, including Cochrane reviews and other evidence summaries.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Definitions&lt;/span&gt;&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Classification of the Quality of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;3&quot; cellpadding=&quot;5&quot; summary=&quot;Table: Grading the Quality of Evidence&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Code&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Quality of Evidence&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Definition&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;A&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;High&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Further research is very unlikely to change confidence in the estimate of effect.&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Several high-quality studies with consistent results &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;In special cases: one large, high-quality multi-centre trial &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;B&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Moderate&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Further research is likely to have an important impact on confidence in the estimate of effect and may change the estimate.&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;One high-quality study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Several studies with some limitations &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;C&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Low&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Further research is very likely to have an important impact on confidence in the estimate of effect and is likely to change the estimate.&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;One or more studies with severe limitations &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;D&lt;/th&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Very Low&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Any estimate of effect is very uncertain.&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Expert opinion &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;No direct research evidence &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;One or more studies with very severe limitations &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;GRADE (Grading of Recommendations Assessment, Development and Evaluation) Working Group 2011 (modified by the EBM Guidelines Editorial Team).&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None provided&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="98" OrdBy="605" ID="425" Name="References Supporting the Recommendations" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Csonka P, Kaila M, Laippala P, Kuusela AL, Ashorn P. Wheezing in early life and asthma at school age: predictors of symptom persistence. Pediatr Allergy Immunol. 2000 Nov;11(4):225-9. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11110576&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Eggesbo M, Halvorsen R, Tambs K, Botten G. Prevalence of parentally perceived adverse reactions to food in young children. Pediatr Allergy Immunol. 1999 May;10(2):122-32. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10478614&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Greer FR, Sicherer SH, Burks AW, American Academy of Pediatrics Committee on Nutrition, American Academy of Pediatrics Section on Allergy and Immunology. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics. 2008 Jan;121(1):183-91. [63 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18166574&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess. 2000;4(37):1-191. [420 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11134919&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Host A, Halken S, Muraro A, Dreborg S, Niggemann B, Aalberse R, Arshad SH, von Berg A, Carlsen KH, Duschen K, Eigenmann PA, Hill D, Jones C, Mellon M, Oldeus G, Oranje A, Pascual C, Prescott S, Sampson H, Svartengren M, Wahn U, Warner JA, Warner JO, Vandenplas Y, Wickman M, Zeiger RS. Dietary prevention of allergic diseases in infants and small children. Pediatr Allergy Immunol. 2008 Feb;19(1):1-4. [19 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18199086&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wuthrich B, EAACI (the European Academy of Allergology and Clinical Immunology) nomenclature. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001 Sep;56(9):813-24. [107 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11551246&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both for preventing or treating atopic disease in the child. In: Cochrane Database of Systematic Reviews [database online]. Issue 3. Hoboken (NJ): John Wiley &amp; Sons, Ltd.; 2006&amp;nbsp;[Art. No.: CD000133]. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2007 Jan;119(1):192-8. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17208601&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol. 2008 Jan;121(1):116-121.e11. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18206506&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Rasanen L, Ylonen K. Food consumption and nutrient intake of one- to two-year-old Finnish children. Acta Paediatr. 1992 Jan;81(1):7-11. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1600309&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Vandenplas Y, Koletzko S, Isolauri E, Hill D, Oranje AP, Brueton M, Staiano A, Dupont C. Guidelines for the diagnosis and management of cow's milk protein allergy in infants. Arch Dis Child. 2007 Oct;92(10):902-8. [42 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17895338&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Venter C, Pereira B, Grundy J, Clayton CB, Roberts G, Higgins B, Dean T. Incidence of parentally reported and clinically diagnosed food hypersensitivity in the first year of life. J Allergy Clin Immunol. 2006 May;117(5):1118-24. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16675341&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Concise summaries of scientific evidence attached to the individual guidelines are the unique feature of the Evidence-Based Medicine Guidelines. The evidence summaries allow the clinician to judge how well-founded the treatment recommendations are. The type of supporting evidence is identified and graded for select recommendations (see the &quot;Major Recommendations&quot; field).&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Appropriate diagnosis and management of food hypersensitivity and allergy in children &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Prevention of food hypersensitivity and allergy in children &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;An implementation strategy was not provided.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Living with Illness" /><FieldValue Value="Staying Healthy" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Finnish Medical Society Duodecim. Food allergy and hypersensitivity in children. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley &amp; Sons; 2010 Dec 1&amp;nbsp;[Various]. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2004 Sep 15 (revised 2010 Dec 1)" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Finnish Medical Society Duodecim - Professional Association" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Finnish Medical Society Duodecim&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Editorial Team of EBM Guidelines&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Primary Author&lt;/em&gt;: Mikael Kuitunen&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Finnish Medical Society Duodecim. Paediatric food hypersensitivity and allergy. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley &amp;amp; Sons; 2008 Apr 10 [Various]. [13 references]&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This guideline is included in &quot;EBM Guidelines. Evidence-Based Medicine&quot; available from Duodecim Medical Publications, Ltd, PO Box 713, 00101 Helsinki, Finland; e-mail: &lt;a href=&quot;mailto:info@ebm-guidelines.com&quot;&gt;info@ebm-guidelines.com&lt;/a&gt;; Web site: &lt;a href=&quot;http://www.ebm-guidelines.com&quot; title=&quot;EBM Guidelines Web site&quot;&gt;www.ebm-guidelines.com&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None available&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None available&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI on August 29, 2005. This summary was updated by ECRI on February 27, 2007. This NGC summary was updated by ECRI Institute on September 27, 2008. This NGC summary was updated by ECRI Institute on March 26, 2012.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
